Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

被引:52
|
作者
Forconi, Francesco [1 ]
Rinaldi, Andrea [2 ]
Kwee, Ivo [2 ,3 ]
Sozzi, Elisa [1 ]
Raspadori, Donatella [1 ]
Rancoita, Paola M. V. [2 ,3 ]
Scandurra, Marta [2 ]
Rossi, Davide [4 ,5 ]
Deambrogi, Clara [4 ,5 ]
Capello, Daniela [4 ,5 ]
Zucca, Emanuele [6 ]
Marconi, Daniela [5 ,7 ]
Bomben, Riccardo [7 ]
Gattei, Valter
Lauria, Francesco [1 ]
Gaidano, Gianluca [4 ,5 ]
Bertoni, Francesco [2 ]
机构
[1] Univ Siena, Dipartimento Med Clin & Sci Immunol, Sez Ematol & Trapianti, I-53100 Siena, Italy
[2] Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland
[3] Ist Dalle Molle Studi Intelligenza Artificiale, Manno, Switzerland
[4] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Genet Clin & Sperimentale, Div Ematol, Novara, Italy
[5] Univ Piemonte Orientale Amedeo Avogadro, BRMA, Novara, Italy
[6] Oncol Inst So Switzerland, Lymphoma Unit, Bellinzona, Switzerland
[7] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, PN, Italy
基金
瑞士国家科学基金会;
关键词
chronic lymphocytic leukaemia; 17p13; deletion; TP53; genome-wide DNA profile; 250K Affymetrix; single nucleotide polymporphysms;
D O I
10.1111/j.1365-2141.2008.07373.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deletion of 17p (TP53) identifies a rare subset of chronic lymphocytic leukaemia (17p- CLL) with aggressive behaviour. Genome-wide DNA-profiling was performed to investigate 18 patients with 17p- CLL. All cases had multiple copy-number (CN) changes. Among the several recurrent CN changes identified, 8q24.13-q24.1-gain (MYC), 8p-loss (TNFRSF10A/B, also known as TRAIL1/2) and 2p16.1-p14-gain (REL/BCL11A) appeared frequently represented. 8p-loss and 2p16.1-p14-gain also appeared clinically relevant and predicted significant shorter time from diagnosis to treatment (8p-loss) and overall survival (8p-loss and 2p16.1-p14-gain, P < 0.05). These observations document a highly unstable genome in 17p- CLL and suggest that additional genes outside the TP53 locus may be important for tumour behaviour.
引用
收藏
页码:532 / 536
页数:5
相关论文
共 50 条
  • [41] Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China
    Heng Li
    Wenjie Xiong
    Huimin Liu
    Shuhua Yi
    Zhen Yu
    Wei Liu
    Rui Lyu
    Tingyu Wang
    Dehui Zou
    Zengjun Li
    Lugui Qiu
    ChineseJournalofCancerResearch, 2017, 29 (02) : 156 - 165
  • [42] Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia (CLL) with 17p deletion: A retrospective EBMT analysis
    Schetelig, Johannes
    van Biezen, Anja
    Caballero, Dolores
    Rodrigo, Martino
    Remes, Kari
    Garcia-Marco, Jose A.
    Volin, Liisa
    Perez-Simon, Jose A.
    Schmitz, Norbert
    Schwerdtfeger, Rainer
    Ganser, Arnold
    Soligo, Davide
    Mohr, Brigitte
    Stilgenbauer, Stephan
    Brand, Ronald
    Ehninger, Gerhard
    de Witte, Theo
    Dreger, Peter
    BLOOD, 2007, 110 (11) : 22A - 23A
  • [43] Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China
    Li, Heng
    Xiong, Wenjie
    Liu, Huimin
    Yi, Shuhua
    Yu, Zhen
    Liu, Wei
    Lyu, Rui
    Wang, Tingyu
    Zou, Dehui
    Li, Zengjun
    Qiu, Lugui
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (02) : 156 - 165
  • [44] Multicentre Genome Wide Association Study Identifies Risk Alleles for Progressive Chronic Lymphocytic Leukaemia
    Allsup, David
    Lin, Wei Yu
    Fordham, Sarah Elizabeth
    Sunter, Nicola
    Elstob, Claire
    Rahman, Thahira
    Willmore, Elaine
    Shepherd, Colin
    Strathdee, Gordon
    Barrow, Timothy
    Mainou-Fowler, Tryfonia
    Piddock, Rachel
    Marr, Helen
    Wallis, Jonathan
    Marshall, Scott R.
    Summerfield, Geoffery
    Pettitt, Andrew
    Pepper, Chris
    Fegan, Christopher
    Forconi, Francesco
    Dyer, Martin J. S.
    Jayne, Sandrine
    Sellors, April
    Schuh, Anna
    Robbe, Pauline
    Oscier, David
    Houlston, Richard S.
    Bailey, James
    Rais, Syed Ashar
    Bentley, Alison
    Cawkwell, Lynn
    Hillmen, Peter
    Pratt, Guy
    Allan, James M.
    BLOOD, 2019, 134
  • [45] Zanubrutinib monotherapy for patients with treatment-naive chronic lymphocytic leukemia and 17p deletion
    Tam, Constantine S.
    Robak, Tadeusz
    Ghia, Paolo
    Kahl, Brad S.
    Walker, Patricia
    Janowski, Wojciech
    Simpson, David
    Shadman, Mazyar
    Ganly, Peter S.
    Laurenti, Luca
    Opat, Stephen
    Tani, Monica
    Ciepluch, Hanna
    Verner, Emma
    Simkovi, Martin
    Osterborg, Anders
    Trneny, Marek
    Tedeschi, Alessandra
    Paik, Jason C.
    Kuwahara, Sowmya B.
    Feng, Shibao
    Ramakrishnan, Vanitha
    Cohen, Aileen
    Huang, Jane
    Hillmen, Peter
    Brown, Jennifer R.
    HAEMATOLOGICA, 2021, 106 (09) : 2354 - 2363
  • [46] SUCCESSFUL TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA SHOWING 17P DELETION WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND ALEMTUZUMAB
    Montillo, M.
    Tedeschi, A.
    Ricci, F.
    Miqueleiz, S.
    Vismara, E.
    Greco, A.
    Colombo, C.
    Mura, M. A.
    Veronese, S.
    Morra, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 370 - 371
  • [47] Genome-wide analysis of chromosomal alterations in Chronic Lymphocytic leukemia
    Strefford, Jonathan
    JOURNAL OF MEDICAL GENETICS, 2009, 46 : S35 - S35
  • [48] GENOME-WIDE ANALYSIS OF GENETIC ALTERATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Parker, Anton
    Parker, Helen
    Gardner, Anne
    Chaplin, Tracy
    Young, Bryan D.
    Oscier, David G.
    Strefford, Jon C.
    CELLULAR ONCOLOGY, 2009, 31 (02) : 124 - 124
  • [49] Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study
    O'Brien, Susan
    Jones, Jeffrey A.
    Coutre, Steven E.
    Mato, Anthony R.
    Hillmen, Peter
    Tam, Constantine
    Osterborg, Anders
    Siddiqi, Tanya
    Thirman, Michael J.
    Furman, Richard R.
    Ilhan, Osman
    Keating, Michael J.
    Call, Timothy G.
    Brown, Jennifer R.
    Stevens-Brogan, Michelle
    Li, Yunfeng
    Clow, Fong
    James, Danelle F.
    Chu, Alvina D.
    Hallek, Michael
    Stilgenbauer, Stephan
    LANCET ONCOLOGY, 2016, 17 (10): : 1409 - 1418
  • [50] Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
    Berndt, Sonja I.
    Skibola, Christine F.
    Joseph, Vijai
    Camp, Nicola J.
    Nieters, Alexandra
    Wang, Zhaoming
    Cozen, Wendy
    Monnereau, Alain
    Wang, Sophia S.
    Kelly, Rachel S.
    Lan, Qing
    Teras, Lauren R.
    Chatterjee, Nilanjan
    Chung, Charles C.
    Yeager, Meredith
    Brooks-Wilson, Angela R.
    Hartge, Patricia
    Purdue, Mark P.
    Birmann, Brenda M.
    Armstrong, Bruce K.
    Cocco, Pierluigi
    Zhang, Yawei
    Severi, Gianluca
    Zeleniuch-Jacquotte, Anne
    Lawrence, Charles
    Burdette, Laurie
    Yuenger, Jeffrey
    Hutchinson, Amy
    Jacobs, Kevin B.
    Call, Timothy G.
    Shanafelt, Tait D.
    Novak, Anne J.
    Kay, Neil E.
    Liebow, Mark
    Wang, Alice H.
    Smedby, Karin E.
    Adami, Hans-Olov
    Melbye, Mads
    Glimelius, Bengt
    Chang, Ellen T.
    Glenn, Martha
    Curtin, Karen
    Cannon-Albright, Lisa A.
    Jones, Brandt
    Diver, W. Ryan
    Link, Brian K.
    Weiner, George J.
    Conde, Lucia
    Bracci, Paige M.
    Riby, Jacques
    NATURE GENETICS, 2013, 45 (08) : 868 - 876